Li, Zhipeng <br/><br/>
Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.  [electronic resource] 

 -  British journal of cancer  02 2019 
 - 306-316 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/s41416-018-0351-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride--administration & dosage<br/>Gefitinib--administration & dosage<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>I-kappa B Kinase--antagonists & inhibitors<br/>Mice<br/>NF-kappa B--genetics<br/>Oxazines--pharmacology<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyridines--pharmacology<br/>Receptor, ErbB-2--genetics<br/>Receptor, ErbB-3--genetics<br/>Signal Transduction--drug effects<br/>Squamous Cell Carcinoma of Head and Neck--drug therapy<br/>TOR Serine-Threonine Kinases--genetics<br/>Xenograft Model Antitumor Assays